Canada Pension Plan Investment Board cut its position in Nu Skin Enterprises, Inc. (NYSE: NUS – Get Rating) by 41.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 23,300 shares of the company stock after selling 16,700 shares during the quarter. Canada Pension Plan Investment Board’s holdings in Nu Skin Enterprises were worth $ 1,182,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Morgan Stanley lifted its position in shares of Nu Skin Enterprises by 1.9% during the 2nd quarter. Morgan Stanley now owns 360,382 shares of the company stock valued at $ 20,415,000 after acquiring an additional 6,652 shares during the period. Geode Capital Management LLC lifted its position in shares of Nu Skin Enterprises by 2.0% during the 3rd quarter. Geode Capital Management LLC now owns 894,968 shares of the company stock valued at $ 36,219,000 after acquiring an additional 17,566 shares during the period. Credit Suisse AG lifted its position in shares of Nu Skin Enterprises by 13.3% during the 3rd quarter. Credit Suisse AG now owns 54,307 shares of the company stock valued at $ 2,197,000 after acquiring an additional 6,391 shares during the period. Macquarie Group Ltd. lifted its position in shares of Nu Skin Enterprises by 6.3% during the 3rd quarter. Macquarie Group Ltd. now owns 20,167 shares of the company stock valued at $ 816,000 after acquiring an additional 1,200 shares during the period. Finally, Hsbc Holdings PLC lifted its position in shares of Nu Skin Enterprises by 42.6% during the 3rd quarter. Hsbc Holdings PLC now owns 19,785 shares of the company stock valued at $ 804,000 after acquiring an additional 5,914 shares during the period. Institutional investors and hedge funds own 93.79% of the company stock.
In other news, Chairman Steven Lund sold 925 shares of the stock in a transaction dated Wednesday, May 18th. The stock was sold at an average price of $ 46.07, for a total value of $ 42,614.75. Following the completion of the sale, the chairman now owns 179,449 shares of the company stock, valued at $ 8,267,215.43. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Andrew D. Lipman sold 1,000 shares of the stock in a transaction dated Friday, April 22nd. The shares were sold at an average price of $ 47.72, for a total value of $ 47,720.00. Following the completion of the sale, the director now directly owns 71,214 shares of the company stock, valued at approximately $ 3,398,332.08. The disclosure for this sale can be found here. In the last three months, insiders sold 71,993 shares of company stock valued at $ 3,285,827. Insiders own 2.80% of the company stock.
A number of analysts have recently weighed in on NUS shares. Jefferies Financial Group upped their target price on Nu Skin Enterprises from $ 61.00 to $ 75.00 in a research report on Thursday, February 17th. StockNews.com upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Thursday. TheStreet upgraded Nu Skin Enterprises from a “c +” rating to a “b” rating in a research report on Tuesday, June 7th. Finally, DA Davidson upped their price target on Nu Skin Enterprises from $ 47.00 to $ 50.00 and gave the stock a “neutral” rating in a research report on Thursday, February 17th. Two investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $ 61.50.
Shares of NUS opened at $ 45.40 on Friday. Nu Skin Enterprises, Inc. has a 12-month low of $ 39.40 and a 12-month high of $ 61.45. The business has a 50-day simple moving average of $ 46.33 and a two-hundred day simple moving average of $ 48.09. The company has a quick ratio of 0.95, a current ratio of 1.72 and a debt-to-equity ratio of 0.28. The stock has a market cap of $ 2.28 billion, a PE ratio of 16.81 and a beta of 1.23.
Nu Skin Enterprises (NYSE: NUS – Get Rating) last issued its earnings results on Wednesday, May 4th. The company reported $ 0.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $ 0.73 by $ 0.03. Nu Skin Enterprises had a return on equity of 22.05% and a net margin of 5.28%. The business had revenue of $ 604.90 million during the quarter, compared to analysts’ expectations of $ 579.70 million. During the same quarter in the prior year, the firm earned $ 0.91 EPS. The business’s revenue for the quarter was down 10.7% compared to the same quarter last year. On average, equities research analysts expect that Nu Skin Enterprises, Inc. will post 3.8 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Wednesday, June 8th. Stockholders of record on Friday, May 27th were paid a $ 0.385 dividend. The ex-dividend date was Thursday, May 26th. This represents a $ 1.54 annualized dividend and a dividend yield of 3.39%. Nu Skin Enterprises’s payout ratio is 57.04%.
About Nu Skin Enterprises: (Get Rating)
Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.
Featured Stories:
Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE: NUS – Get Rating).
Receive News & Ratings for Nu Skin Enterprises Daily: – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Nu Skin Enterprises and related companies with MarketBeat.com’s FREE daily email newsletter.
.